View in EDS HTML Full Text PDF Full Text

Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity.

Saved in:
Bibliographic Details
Title: Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity.
Authors: He B; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Wood KH; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Li ZJ; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.; Department of Geriatrics and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Guangdong, P. R. China., Ermer JA; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Li J; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Bastow ER; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Sakaram S; INSiGENe Pty Ltd, UGenome, Tucson, AZ, USA., Darcy PK; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Spalding LJ; Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Redfern CT; Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia., Canes J; SOLTI Cancer Research Group, Barcelona, Spain., Oliveira M; SOLTI Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Prat A; SOLTI Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Cortes J; SOLTI Cancer Research Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas&Co, Jersey City, NJ, USA.; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas&Co, Sao Paulo, Brazil.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.; IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid, Spain., Thompson EW; School of Biomedical Sciences and Centre for Genomics and Personalised Health, Faculty of Health, Queensland University of Technology (QUT) and Translational Research Institute, Brisbane, Australia., Littlefield BA; Eisai Inc., Cambridge, MA, USA., Redfern A; Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.; Fiona Stanley Hospital, Perth, WA, Australia., Ganss R; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia. ganss@perkins.uwa.edu.au.
Source: EMBO molecular medicine [EMBO Mol Med] 2025 May; Vol. 17 (5), pp. 1071-1100. Date of Electronic Publication: 2025 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40140727
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22He+B%22">He B</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Wood+KH%22">Wood KH</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Li+ZJ%22">Li ZJ</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.; Department of Geriatrics and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Guangdong, P. R. China.<br /><searchLink fieldCode="AU" term="%22Ermer+JA%22">Ermer JA</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Bastow+ER%22">Bastow ER</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Sakaram+S%22">Sakaram S</searchLink>; INSiGENe Pty Ltd, UGenome, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Darcy+PK%22">Darcy PK</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Spalding+LJ%22">Spalding LJ</searchLink>; Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Redfern+CT%22">Redfern CT</searchLink>; Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Canes+J%22">Canes J</searchLink>; SOLTI Cancer Research Group, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Oliveira+M%22">Oliveira M</searchLink>; SOLTI Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Prat+A%22">Prat A</searchLink>; SOLTI Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cortes+J%22">Cortes J</searchLink>; SOLTI Cancer Research Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas&Co, Jersey City, NJ, USA.; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas&Co, Sao Paulo, Brazil.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.; IOB Madrid, Institute of Oncology, Hospital Beata María Ana, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Thompson+EW%22">Thompson EW</searchLink>; School of Biomedical Sciences and Centre for Genomics and Personalised Health, Faculty of Health, Queensland University of Technology (QUT) and Translational Research Institute, Brisbane, Australia.<br /><searchLink fieldCode="AU" term="%22Littlefield+BA%22">Littlefield BA</searchLink>; Eisai Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Redfern+A%22">Redfern A</searchLink>; Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia.; Fiona Stanley Hospital, Perth, WA, Australia.<br /><searchLink fieldCode="AU" term="%22Ganss+R%22">Ganss R</searchLink>; Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, Centre for Medical Research, The University of Western Australia, Perth, WA, Australia. ganss@perkins.uwa.edu.au.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2025 May; Vol. 17 (5), pp. 1071-1100. <i>Date of Electronic Publication: </i>2025 Mar 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40140727
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44321-025-00222-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1071
    Titles:
      – TitleFull: Selective tubulin-binding drugs induce pericyte phenotype switching and anti-cancer immunity.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: He B
      – PersonEntity:
          Name:
            NameFull: Wood KH
      – PersonEntity:
          Name:
            NameFull: Li ZJ
      – PersonEntity:
          Name:
            NameFull: Ermer JA
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Bastow ER
      – PersonEntity:
          Name:
            NameFull: Sakaram S
      – PersonEntity:
          Name:
            NameFull: Darcy PK
      – PersonEntity:
          Name:
            NameFull: Spalding LJ
      – PersonEntity:
          Name:
            NameFull: Redfern CT
      – PersonEntity:
          Name:
            NameFull: Canes J
      – PersonEntity:
          Name:
            NameFull: Oliveira M
      – PersonEntity:
          Name:
            NameFull: Prat A
      – PersonEntity:
          Name:
            NameFull: Cortes J
      – PersonEntity:
          Name:
            NameFull: Thompson EW
      – PersonEntity:
          Name:
            NameFull: Littlefield BA
      – PersonEntity:
          Name:
            NameFull: Redfern A
      – PersonEntity:
          Name:
            NameFull: Ganss R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1757-4684
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: EMBO molecular medicine
              Type: main
ResultId 1